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OBJECTIVE — The goal of this study was to determine the effect of artiﬁcial sweeteners on
glucose, insulin, and glucagon-like peptide (GLP)-1 in humans.
RESEARCH DESIGN AND METHODS — For this study, 22 healthy volunteers (mean
age 18.5  4.2 years) underwent two 75-g oral glucose tolerance tests with frequent measure-
ments of glucose, insulin, and GLP-1 for 180 min. Subjects drank 240 ml of diet soda or
carbonated water, in randomized order, 10 min prior to the glucose load.
RESULTS — Glucose excursions were similar after ingestion of carbonated water and diet
soda. Serum insulin levels tended to be higher after diet soda, without statistical signiﬁcance.
GLP-1 peak and area under the curve (AUC) were signiﬁcantly higher with diet soda (AUC
24.015.2pmol/lper180min)versuscarbonatedwater(AUC16.29.0pmol/lper180min;
P  0.003).
CONCLUSIONS — ArtiﬁcialsweetenerssynergizewithglucosetoenhanceGLP-1releasein
humans. This increase in GLP-1 secretion may be mediated via stimulation of sweet-taste recep-
tors on L-cells by artiﬁcial sweetener.
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C
onsumption of sodas containing ar-
tiﬁcial sweeteners is common prac-
tice in both children and adults. It is
generally assumed that glucose metabo-
lism is not altered because these sodas
contain no or extremely few calories from
carbohydrate. However, recent data ob-
tained from animal studies demonstrate
that artiﬁcial sweeteners play an active
metabolic role within the gastrointestinal
tract. Sweet-taste receptors, including the
T1Rfamilyand-gustducin,respondnot
only to caloric sugars such as sucrose but
also to artiﬁcial sweeteners, including su-
cralose(Splenda)andacesulfame-K(1,2).
Inbothhumansandanimals,theserecep-
tors have been shown to be present in
glucagon-like peptide (GLP)-1–secreting
L-cells of the gut mucosa as well as in
lingual taste buds (3–5) and serve as crit-
ical mediators of GLP-1 secretion (5). In
this study, we examined the effect of arti-
ﬁcial sweeteners in a commercially avail-
able soft drink on glucose, insulin, and
GLP-1 in humans.
RESEARCH DESIGN AND
METHODS— Forthisstudy,22healthy
subjects 12–25 years of age (18.5  4.2
years, 45% male, 41% Caucasian, 32%
black,27%other,BMI25.64.6kg/m
2)
participated in two 75-g oral glucose tol-
erance tests (OGTTs) on separate days af-
ter a 10-h fast. Subjects drank 240 ml of
either caffeine-free diet soda (Diet Rite
cola) sweetened with sucralose and ace-
sulfame-K or unﬂavored carbonated wa-
ter, in randomized order, 10 min prior to
the glucose load. Each subject served as
his or her own control. Glucose, insulin,
and GLP-1 were measured for 180 min
after the glucose load.
TotalGLP-1wasmeasuredusingara-
dioimmunoassay (Millipore, Billerica,
MA).ThelowestdetectablelevelofGLP-1
was 3 pmol/l using a 300-l extracted
sample (interassay coefﬁcient of variation
[CV] 23% and intraassay CV 22%). Insu-
lin was measured using a chemilumines-
cenceimmunoassaywithanormalfasting
range of 42–188 pmol/l (interassay CV
11.5% at 69 pmol/l and 8.1% at 198
pmol/l; intraassay CV 6.2% at 56 pmol/l
and 4.9% at 429 pmol/l). Serum glucose
wasdeterminedusingtheglucoseoxidase
method (interassay CV 3.9% at 2.4
mmol/l and 1.2% at 22.1 mmol/l; intraas-
say CV 2.9% at 2.4 mmol/l and 0.4% at
22.1 mmol/l).
Area under the curve (AUC) was cal-
culated using the trapezoidal method.
Datafromthedietsodaversuscarbonated
water condition were compared using
paired t tests or Wilcoxon rank-sum test,
as appropriate. Data in the text are pre-
sented as means  SD.
RESULTS— Glucose, insulin, and
GLP-1 concentrations during the OGTTs
are shown in Fig. 1. Glucose excursions
were nearly superimposable in both ex-
perimental settings (AUC with carbon-
ated water 1,123  152 mmol/l per 180
minvs.dietsoda1,112138mmol/lper
180 min; P  0.64). Although insulin re-
sponses tended to be more pronounced
20 and 25 min after glucose ingestion in
the diet soda condition, these differences
did not reach statistical signiﬁcance (20
P  0.20; 25 P  0.28). Insulin AUCs
were not statistically different (carbon-
ated water 62,540  7,646 pmol/l per
180 min vs. diet soda 62,164  7,688
pmol/l per 180 min; P  0.75). Peak in-
sulin levels occurred 12.3 min earlier in
the diet soda condition; however, again
this difference was not statistically signif-
icant (P  0.12).
The GLP-1 AUC was signiﬁcantly
higherwithdietsoda(24.015.2pmol/l
per 180 min) than carbonated water
(16.2  9.0 pmol/l per 180 min; P 
0.003). In addition, the GLP-1 peak was
signiﬁcantly higher with diet soda versus
carbonated water (P  0.003), whereas
the timing of the peak was not altered.
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or glucose, artiﬁcial sweeteners in the ab-
sence of carbohydrate do not appear to
stimulate GLP-1 secretion in humans (6)
or animals (7). However, our data dem-
onstrate that artiﬁcial sweeteners syner-
gize with glucose to enhance GLP-1
release in healthy young volunteers. Fur-
thermore, this effect was observed with
small quantities of artiﬁcial sweetener
found in 240 ml (two-thirds of a can) of a
commercially available soda, suggesting
thattheeffectmayberelevantineveryday
life.
Because artiﬁcial sweeteners were
given by mouth in the form of diet soda,
one might hypothesize that increases in
insulin and GLP-1 were due to cephalic-
phase insulin release. This is unlikely, be-
cause cephalic-phase insulin release
typically occurs 2–10 min after taste ex-
posure and does not occur with pure oral
glucose or artiﬁcial sweeteners (8), and
cephalic-phase GLP-1 response has not
beenobservedinhumans(9).Instead,we
postulate that the enhancement of GLP-1
secretion observed here after diet soda in-
gestionwasduetostimulationofguttaste
receptors by artiﬁcial sweetener, syner-
gizing with glucose-mediated stimulation
of GLP-1 release.
The metabolic consequences of in-
creased GLP-1 release after ingestion of
both artiﬁcial sweeteners and glucose re-
main uncertain. In the present study, no
signiﬁcant differences were observed in
either plasma glucose or insulin after diet
soda versus carbonated water ingestion,
despite the signiﬁcant differences in
GLP-1. In contrast, exogenous GLP-1 in
healthy volunteers results in lower post-
prandial blood glucose and decreased in-
sulin secretion, an effect due primarily to
delayed gastric emptying rather than an
incretin effect (10–12). However, the
pharmacologic doses of GLP-1 used in
these studies resulted in plasma levels 3-
to 10-fold higher than those seen here af-
ter diet soda. In addition, artiﬁcial sweet-
eners likely play a role in glucose
metabolism beyond changes in GLP-1.
There is evidence in animals that activa-
tion of intestinal sweet-taste receptors by
artiﬁcial sweeteners enhances intestinal
glucose absorption via upregulation of
GLUT2 (1). Thus, the kinetics of glucose
and insulin observed in the present study
may have been affected both by changes
inGLP-1andbyalteredintestinalglucose
absorption.
In summary, artiﬁcial sweeteners in
combinationwithglucoseincreaseGLP-1
secretion, but the clinical signiﬁcance of
this observation remains to be deter-
mined. Additional studies are needed to
isolatetheeffectsofindividualsweeteners
in diet sodas and should include individ-
uals with metabolic abnormalities such as
type 2 diabetes, a condition typically as-
sociated with loss of the incretin effect. In
light of the large number of individuals
usingartiﬁcialsweetenersonadailybasis,
itappearsessentialtocarefullyinvestigate
the associated effects on metabolism and
weight.
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